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Abstract
Introduction—A multi-faceted intervention to raise influenza vaccination rates was tested 
among children with asthma.
Methods—In a pre-post design, eighteen primary care practices implemented the 4 Pillars™ 
Immunization Toolkit along with other strategies. The primary outcome was the difference in 
influenza vaccination rates at each practice among children with asthma during the baseline year 
(pre-intervention) and at the end of year 2 (post intervention), both overall and by race (white vs. 
non-white).
Results—Influenza vaccination rates increased significantly in 13 of 18 practices. The percent of 
vaccinated non-white children increased from 46% to 61% (P<0.01) and the percent of vaccinated 
white children increased from 58% to 65% (P<0.001). Likelihood of vaccination was significantly 
lower for non-white children pre-intervention (OR=0.66, 95%CI=0.59–0.73; P<0.001), but this 
difference was eliminated post intervention (OR=0.95, 95%CI=0.85–1.05; P=.289).
Discussion—A multi-strategy, evidence-based intervention significantly increased influenza 
vaccination uptake and reduced racial disparities among children with asthma.
INTRODUCTION
The prevalence of asthma among U.S. children has increased over time to an estimated 6.9 
million children in 2012 (9% of the population less than18 years of age). Asthma prevalence 
is higher among low income and disadvantaged children (13%) than among higher income 
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groups (7–9%), and among black children (16%) than among white and Asian children (5–
8%) (Centers for Disease Control and Prevention, 2013b).
Individuals with asthma are considered to be at high risk for complications of influenza 
infection. For this reason, annual influenza vaccination is an essential element of prevention. 
Inactivated influenza vaccine has been recommended for those with asthma over age 6 
months since the earliest recommendations of the Advisory Committee on Immunization 
Practices (ACIP) (Centers for Disease Control and Prevention). While the most recent 
national influenza vaccination rate for children with asthma (2010–2011) of 53% (Centers 
for Disease Control and Prevention, 2013b) is similar to the rate reported among all children 
6 months – 17 years old during the same time period, (51%) (Centers for Disease Control 
and Prevention, 2011), it is far below the Healthy People 2020 goal of 70% (U.S. 
Department of Health and Human Services, 2013). Moreover, among children with asthma, 
there are disparities in influenza vaccine uptake, which is lower among black children (45%) 
than among white children (51%) and lower among socioeconomically disadvantaged 
children (47%) than among higher income children (54%) (Centers for Disease Control and 
Prevention, 2013b).
Since the 2008 universal recommendation for influenza vaccination of all children 6 months 
of age or older who do not have a contraindication (Fiore AE et al., 2008), little research has 
focused on increasing influenza vaccine uptake specifically among children with asthma or 
other high risk conditions. Moreover, disparities in the rates of influenza vaccination among 
minority and disadvantaged children with asthma have not been addressed.
Recent research among children of all ages has shown that a multi-strategy intervention that 
includes a practice improvement toolkit, staff education, feedback and early delivery of 
vaccines for disadvantaged children can successfully raise influenza vaccination rates and 
reduce racial disparities (Nowalk et al., 2014; Zimmerman RK et al., 2014). The purpose of 
this study was to examine the impact of that intervention on influenza vaccine uptake among 
a subgroup of those children i.e., those with an asthma diagnosis, and to test the 
intervention’s effectiveness for reducing racial disparities in influenza vaccination rates in 
this population.
METHODS
The study was approved by the University of X Institutional Review Board. Methods for 
sample size calculation and randomization have been previously published (Zimmerman RK 
et al., 2014). The parent randomized cluster trial, which met all CONSORT criteria 
(Campbell MK, Piaggio G, Elbourne DR, & DG, 2012), was designed to test the 
effectiveness of a multi-strategy intervention to increase childhood influenza vaccination 
rates among all children in primary care practices. The study took place during three 
influenza seasons; 2010–2011 was the baseline year for all sites, 2011–2012 was the active 
intervention year for one half of the sites and control year for the other half, and 2012–2013 
was the maintenance year for the Year 1 intervention sites and the active intervention year 
for the Year 2 intervention sites. The intervention was the same during both years. At the end 
of Year 2, vaccination rates for all children in both intervention arms were similar (Nowalk 
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MP et al., 2015). This analysis includes only children with asthma, comparing baseline (pre-
intervention) with Year 2 (post intervention) vaccination in a pre/post study design.
Site Selection
To be eligible, each site must have had a patient population of at least 200 children ages 6 
months to 18 years (to satisfy sample size requirements for the cluster trial), access to 
vaccination and asthma diagnosis data via an electronic medical record (EMR) and 
willingness to implement the intervention. Two sites from the parent study were excluded 
because they did not provide asthma information. Primary care pediatric and family 
medicine practices from two practice-based research networks (http://
www.familymedicine.pitt.edu/content.asp?id=2353) and (http://www.pedspittnet.pitt.edu/) in 
Southwestern Pennsylvania were included. All included sites used a common EMR.
Interventions
The intervention was designed using the Diffusion of Innovations Theory (Oldenburg B & 
Parcel SG, 2002), and included the 4 Pillars™ Immunization Toolkit (http://
www.pittvax.pitt.edu/child-flu-toolkit) as well as provider education, early delivery of 
donated vaccines for disadvantaged children and feedback to practices on influenza vaccines 
given and missed opportunities. A description of the intervention and the results for the first 
year of intervention have been previously published (Zimmerman RK et al., 2014). A 
summary of the strategies is included in the Supplemental material (Table A-1). The 4 
Pillars™ Immunization Toolkit, a practice improvement toolkit, was initially developed for 
use in raising adult immunization rates (Nowalk et al., 2012; Nowalk MP et al., 2013) and is 
based on four key evidence-based (Melinkovich, Hammer, Staudenmaier, & Berg, 2007; 
Task Force on Community Preventive Services, 2012) strategies: Pillar 1 – Convenient 
vaccination services; Pillar 2 - Notification of patients about the importance of immunization 
and the availability of vaccines; Pillar 3 - Enhanced office systems to facilitate 
immunization; Pillar 4 - Motivation through an office immunization champion. The toolkit 
includes background on the importance of protecting children against influenza, barriers to 
increasing influenza vaccination from both provider and parent/patient perspectives and 
strategies to eliminate those barriers. Practices were expected to implement strategies from 
each of the 4 pillars.
One of the investigators visited each site in August of their intervention year, prior to 
influenza season, and following a standard procedure, introduced the study and the package 
of interventions at a staff meeting. She then worked with staff to develop site-specific ideas 
for implementing the toolkit selecting at least one strategy from each pillar. During their 
intervention year, sites received donated vaccine for use among disadvantaged children until 
sites received their Vaccines for Children (VFC) vaccines. There was no particular emphasis 
placed on vaccinating children with asthma.
Data collection
De-identified demographic, office visit, influenza vaccination and asthma diagnosis data 
were derived from EMR data extractions. Children were included in the analyses if they 
were “active” patients, defined as having visited one of the participating practice sites 
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between July 1 and February 28/29 for the study year, and if they had ever received an 
asthma diagnosis (ICD 493.00 thru 493.99). The denominator included all active patients 
with asthma who were age 6 months through 18 years, chosen because children are eligible 
to receive influenza vaccine at age 6 months. The numerator was the number of those 
children who had received at least one dose of influenza vaccine during the pre- and post 
intervention periods. Based on EMR data, 74% of children were white, 23% were black or 
African American and 3.6% were “other.” Due to the small number of children in the 
“other” category, children were divided into white and non-white groups for analysis.
Statistical analyses
Chi square tests were used to compare the distribution of demographic variables between 
racial groups at pre-intervention and post intervention. Two sample t-tests were used to 
compare pre- and post intervention vaccination rates overall and within racial groups. Paired 
t-tests were used to compare differences in vaccination within each site between the pre- and 
post intervention.
To determine which factors increased the likelihood that a child would be vaccinated, 
multilevel, generalized estimating equation (GEE) regression analyses were performed using 
influenza vaccination status (vaccinated vs. not vaccinated) as the binary outcome variable. 
The independent variables included patient level age group (<2 years, 2–8 years, 9–18 
years), sex, race (non-white vs. white), insurance type (self/public vs. commercial), number 
and percent of strategies used to increase rates, and a site-level interaction term combining 
race (non-white vs. white) and year (pre- vs. post intervention). Statistical significance of 
two-sided tests was set at alpha equal to 0.05. All analyses were performed using [SAS/
STAT] software, version 9.3 (SAS Institute, Inc. Cary, NC, USA).
RESULTS
Baseline demographic characteristics of children with asthma overall and by race and their 
distributions across age groups, sex, and insurance status are shown in Table 1. At pre-
intervention, just under one-fourth of all children were non-white (23%), more than half 
(58%) were males, and one-third (33%) were self- or publicly insured. Post intervention, 
there were significantly more children in the older age group (9–18 years) and who were 
self- or publicly insured (see Table 1). When comparing racial groups, non-white children 
were more likely to be younger, and self- or publicly-insured compared with white children. 
When combining children from all sites, influenza vaccination uptake increased significantly 
from pre- to post intervention for all children (55.2% to 64.2%; P<0.001) and in both racial 
groups (non-white, 46.3% pre- vs. 61.3% post intervention; white, 57.9% pre- vs. 65.4% 
post intervention; P<0.001).
Table 2 shows the number and percent of children vaccinated at pre- and post intervention 
for all children with asthma, for non-white and white children separately, and the differences 
between years for each group by site. The unweighted mean change in percent of all 
children vaccinated from pre- to post intervention was 12.4 percentage points (P<0.001). 
Among non-white children, the percent vaccinated increased by 14.5 percentage points 
(P<0.01), and among white children, the increase was 11.8 percentage points (P<0.001). 
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Thirteen of eighteen sites significantly improved influenza vaccine uptake overall; however, 
this increase was not consistently distributed across sites and racial groups. For example, 
influenza vaccine uptake increased significantly among white children in 10 sites, but 
increased significantly among non-white children in only six sites.
Using GEE, which accounts for the clustered nature of the data, we found that the likelihood 
of vaccination (Table 3) was lower among older children (9–18 years) compared with 
children <2 years (Odds Ratio [OR] = 0.29; 95% Confidence Interval [CI] = 0.25–0.35) and 
lower among children 2–8 years compared with those <2 years of age (OR = 0.48; 95%CI = 
0.41–0.57). Overall, commercially insured children, males and white children were more 
likely to be vaccinated than self- or publicly insured children, females and non-white 
children, respectively. Because we observed an overall change in the vaccination rate among 
non-white children that was higher than among white children, an interaction term of race 
and year was included in the model. At baseline, the likelihood of influenza vaccination for 
non-white children was significantly lower than that for white children (OR = 0.66; 95%CI 
= 0.59–0.83; P<0.001). After the two-year intervention, non-white children were equally 
likely to have been vaccinated as white children (OR = 0.95; 95%CI = 0.85–1.05; P=0.289).
DISCUSSION
Given the decades-long recommendation for influenza vaccination for children with asthma 
because of the potentially severe consequences of influenza infection in these children, it is 
unclear why national influenza vaccination rates among children with asthma (53%, 2010–
2011) (Centers for Disease Control and Prevention, 2011) have only marginally surpassed 
those of children without high risk conditions (52%, 2011–2012) (Centers for Disease 
Control and Prevention, 2013a).
Interventions to increase influenza vaccination among children with asthma have been scant 
since universal influenza vaccination recommendations were made in 2008. Moreover, none 
of the identified intervention studies specifically addressed the racial disparities observed in 
influenza vaccination rates among children with asthma. Not only are there more minority 
children with an asthma diagnosis in the United States (Centers for Disease Control and 
Prevention, 2013b), but their risk from complications of influenza is higher as well, due to 
lower influenza vaccination uptake. Addressing these racial disparities is an unmet need.
We undertook a two-year study using a multi-strategy intervention to increase influenza 
vaccination among all children in participating practices; the intervention included a practice 
improvement toolkit, staff education and early delivery of donated influenza vaccine for 
disadvantaged children. This analysis focused on influenza vaccination coverage for children 
with asthma and examined pre-post intervention vaccination differences by race. We 
observed significant increases in influenza vaccine uptake in 13 of 18 sites with overall 
vaccination increasing 9.0 percentage points. In a previous report among children not 
distinguished by asthma diagnosis, vaccination increased 12.7 percentage points over two 
years (Nowalk MP et al., 2015).
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At baseline, the percent of non-white children vaccinated against influenza was notably 
lower than white children and the likelihood of vaccination among non-white children 
compared with white children was significantly lower. Over the two year intervention, the 
percent of children vaccinated increased significantly in both racial groups, reaching an 
overall level (64%) which is higher than the national rate of 53% (Centers for Disease 
Control and Prevention, 2011). Furthermore, the likelihood of vaccination post intervention 
no longer differed between racial groups, indicating that the intervention was successful for 
both non-white and white children with asthma. This finding is consistent with previous 
findings among children with and without asthma, in which the likelihood of vaccination for 
non-white children (Nowalk et al., 2014) was greater in the intervention group than in the 
control group.
A recent analysis of racial and ethnic disparities in influenza vaccination among adults 
found that lower vaccination rates persist among non-Hispanic blacks and Hispanics, 
compared with non-Hispanic whites in the general population (Lu et al., 2014). Overall 
increases in influenza vaccination coverage among adults were not associated with 
diminished differences among racial and ethnic groups. Thus, the authors recommended 
targeted interventions to eliminate racial disparities in influenza vaccination among adults.
In contrast, our findings among children with asthma suggest that primary care practices that 
care for children may not need to target specific groups for intervention if they are 
implementing a multi-strategy intervention to improve influenza vaccine uptake. By using 
strategies outlined in the 4 Pillars™ Immunization Toolkit such as, changing access to 
vaccination through convenient express vaccination services, creating opportunities to 
inform parents about vaccine recommendations, increasing availability and express services, 
modifying office systems to remind providers, allowing non-physician staff to vaccinate 
without a written order, and encouraging the efforts of office personnel to promote 
vaccination, influenza vaccine uptake can increase among all children with asthma, 
including racial minorities.
Strengths and Limitations
We were unable to determine which children were first-time vaccinees and required two 
doses, thus children under age 9 years who received at least one dose of vaccine were 
counted in the numerator as “vaccinated.” We could not separately analyze data for those 
partially and fully vaccinated. Several sites did not improve vaccination rates significantly. 
Four of these were large urban/suburban practices with relatively high rates pre-intervention. 
We previously reported a possible threshold effect, above which efforts by the primary care 
practice may not be effective for further increasing rates (Zimmerman RK et al., 2014). To 
date, this study is one of few to examine the effect of an evidence-based intervention on 
influenza vaccination rates among children with asthma since universal influenza 
vaccination has been recommended. Only one previous non-randomized study was identified 
that looked at the relationship of a similar set of interventions in a toolkit on rates among 
high-risk children and adolescents (Britto, Schoettker, Pandzik, Weiland, & Mandel, 2007). 
Notwithstanding, this pre-post study of influenza vaccination uptake among approximately 
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8,000 children with asthma in 18 primary care practices is singular in its comparisons 
between non-white and white children.
Conclusions
A practice improvement toolkit, along with staff education and early delivery of vaccine for 
disadvantaged children and provider feedback, appears to be an effective tool for improving 
influenza vaccine uptake among children with asthma over two years. Increases in overall 
vaccination helped to reduce vaccination disparities between non-white and white children.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Demographic characteristics and influenza vaccine uptake of children with asthma across 18 primary care 
practices
Characteristic All children Non-white children White children
Pre-intervention N=8250 N=1902 N=6348
Age group, n (%)*
 <2 530 (6.4) 188 (9.9) 342 (5.4)
 2–8 3826 (46.4) 929 (48.8) 2897 (45.6)
 9–17 3894 (47.2) 785 (41.3) 3109 (49.0)
Sex, n (%)
 Male 4786 (58.0) 1140 (59.9) 3646 (57.4)
 Female 3464 (42.0) 762 (40.1) 2702 (42.6)
Insurance, n (%)*
 Commercial 5537 (67.1) 727 (38.2) 4810 (75.8)
 Self/public 2713 (32.9) 1175 (61.8) 1538 (24.2)
Influenza vaccination (%) 4555 (55.2) 881 (46.3) 3674 (57.9)
Post intervention N=8487 N=2492 N=5995
Age group, n (%)*
 <2 225 (2.7) 110 (4.4)** 115 (1.9)**
 2–8 3673 (43.3) 1223 (49.1) 2450 (40.9)
 9–17 4589 (54.1) 1159 (46.5) 3430 (57.2)
Sex, n (%)
 Male 5003 (59.0) 1486 (59.6) 3517 (58.7)
 Female 3484 (41.1) 1006 (40.4) 2478 (41.3)
Insurance, n (%)*
 Commercial 5179 (61.0) 741 (29.7)** 4438 (74.0)†
 Self/public 3308 (39.0) 1751 (70.3) 1557 (26.0)
Influenza vaccination, n (%) 5449 (64.2)** 1528 (61.3)** 3921 (65.4)**
Pre-post difference in vaccination rate (%) 9.0 15.0 7.5
*
P<0.001 for differences in distributions between race categories
**
P<0.001 for pre-post comparisons within race;
†
P<0.05 for pre-post comparisons within race
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